You are here: Industry Insights > India

News List

Mylan launches MyHep All in India expressbpd
July 31, 2017
MyHep All is a fixed-dose combination of Velpatasvir 100 mg/ Sofosbuvir 400 mg tablets
Unicity International launches genomeceuticals range of products in India financialexpress
July 14, 2017
Unicity uses genomeceuitical technology in its products to support proper gene expression, which helps maintain healthy body function at their most basic levels
India and Israel launch Innovation bridge for startups biospectrumasia
July 11, 2017
There will be comprehensive guides and toolkits to help startups explore expansion opportunities.
With Brexit we hope to see more companies from India set up a footprint in Ireland biospectrumasia
July 11, 2017
To encourage more investments into Ireland by foreign-owned companies, Martin D. Shanahan, CEO of IDA Ireland was in India during the first week of June by meeting companies in Mumbai, New Delhi and Bangalore.
BIOCAD’s rituximab biosimilar to receive MA in India cphi-online
July 06, 2017
First shipment of BIOCAD’s Acellbia to India is scheduled for September 2017.
Domino Printech India to launch Ax-Series financialexpress
July 04, 2017
The new range of continuous ink jet will reset customer expectations of productivity, quality and cost of ownership
Domino Printech India to launch Ax-Series expressbpd
July 04, 2017
The new range of continuous ink jet will reset customer expectations of productivity, quality and cost of ownership
India's Glenmark signs license agreement for APC Therapeutics’ small molecule oncology compound pharmaceutical-technology
June 28, 2017
India-based Glenmark Pharmaceuticals has entered a licensing agreement with US company APC Therapeutics for exclusive rights to a small molecule, oncology compound based on antigen presenting cell (APC) biology.
AstraZeneca initiates recall of BRILINTA biospectrumasia
June 07, 2017
The voluntary nationwide recall of one lot of BRILINTA 90 mg professional sample bottles by AstraZeneca follows after a report of another medicine, ZURAMPIC in one bottle from that lot.
'Now, India has a balanced, scientific regulatory framework for clinical trials' biospectrumasia
June 07, 2017
"With only 1.4% of global clinical trials in a country that has the highest disease burden in the world, we need to encourage more sponsors to conduct clinical research in India as well as create a strong eco system for indigenous innovation and R&D," say

Previous page 1 2 3 4 5 6 7 8 9 10 ... 33 34 Next page